Investment Banking Team
Rick Herbst, Partner
Rick Herbst, partner-in-charge, has over 20 years of experience in general management, strategy and consulting. Prior to joining Sikich, Rick was a general manager and vice president of a North American e-commerce unit and was also a partner in a strategy consulting group, where he led global e-commerce strategy and the central region information technology, high-tech and telecommunications strategy practices. Rick is registered with the Financial Industry Regulatory Authority (FINRA) as a Series 24 General Securities Principal, a Series 7 General Securities Representative, a Series 79 Investment Banking Representative and a Series 99 Operations Professional.
Education: M.B.A., University of Chicago Booth School of Business, B.B.A., University of Texas
Joe O’Neill, Managing Director
Joe O’Neill, managing director, has over 25 years of experience in developing and growing businesses throughout the world. Today, his work is focused on investment banking for high-growth technology companies. Prior to joining Sikich, Joe specialized in mobile and wireless technology, mobile payment, clean-tech, social media, social networking and enterprise software. Joe is a published author and industry speaker, and is registered with FINRA as a Series 7 General Securities Representative and a Series 79 Limited Investment Banking Representative.
Education: M.B.A., Thunderbird School of Global Management, B.A., Lafayette College
Evan Anderson, Director
Evan Anderson, director, manages select advisory engagements where Intellectual Property (IP) may be a company’s raison d’être. Evan draws from years of experience from earlier careers leading sell-side IP transactions and as an investment banker, leading M&A advisory engagements and directing private capital raises and corporate venture capital investments. Evan is also a registered Patent Attorney. Evan focuses on the nexus of technology, intellectual property and investment banking executing primarily IP-centric M&A transactions and technology divestitures. He is registered with FINRA as a Series 79 Investment Banking Representative.
Education: M.B.A., University of Southern California – Marshall School of Business, J.D., Valparaiso University School of Law, B.A., Biological Sciences, DePauw University
Thomas L. Davenport II, Director
Thomas Davenport, director, is registered with FINRA as a Series 7 General Securities Representative and a Series 79 Investment Banking Representative. In his current role, Thomas leads the Industrial Practice and distressed opportunities. Prior to joining Sikich, Thomas was the founder and Managing Partner of Davenport Capital Management (DCM), a boutique investment bank. Before founding DCM, Thomas was an investment banker and a member of Industrials and Mergers & Acquisitions teams.
Education: M.B.A., University of Chicago Booth School of Business, B.A., Morehouse College
Kurt Estes, Director
Kurt Estes, director, has 20 years of transaction experience that includes investing in or creating businesses around innovative technologies. He has conducted or managed over 50 venture capital transactions covering all stages of a startup’s life, from seed through mezzanine to liquidity events. In his current role, Kurt is responsible for leading the Investment Banking’s Technology Services Practice. Kurt is also responsible for Corporate Development for Sikich as a whole. He is registered with FINRA as a Series 7 General Securities Representative and a Series 79 Investment Banking Representative.
Education: M.B.A., Kellogg Graduate School of Management, Northwestern University, M.S. Mechanical Engineering, Purdue University, B.S. Mechanical Engineering, Purdue University
Susan Tomilo, Director
Susan Tomilo, director, has over 15 years of experience in strategy, general management and consulting roles advising public and private companies in high technology, software and health care industries. In her current role, Susan leads the Healthcare and Life Science Practice and buy-side efforts. Susan was previously a Director at a boutique investment bank, where she focused on mergers and acquisitions and strategic advisory for privately-held companies and Venture Funds. Susan is registered with FINRA as a Series 7 General Securities Representative and a Series 79 Investment Banking Representative.
Education: M.B.A., University of Chicago Booth School of Business, B.B.A., University of Michigan
Adam Elhofy, PHD, Vice President
Adam Elhofy, vice president, has over 14 years of scientific research experience in the areas of immunology, neuroscience and oncology. Adam leads the scientific evaluations of many due diligence efforts for the Life Science Funds that Sikich advises on an ongoing basis. Previously, Adam led the proof of principle efforts and applied for SBIR funding for a nanotech startup. As a consultant, he has developed a pathway to market models for both novel therapeutics and new uses of existing products. Adam has 12 scientific publications in peer reviewed journals.
Education: Ph.D., University of North Carolina, M.B.A., Kellogg Graduate School of Management, Northwestern University, B.A. Biology, University of Maryland
Paul Graver, Associate
Paul Graver, associate, has more than seven years of investment banking and private equity experience across a diverse set of industries. Prior to joining Sikich, Paul worked at a boutique investment bank, where he focused on mergers and acquisitions and strategic advisory for entrepreneur-owned firms. Paul’s previous experience also includes making direct investments in the industrial, financial services, business services, consumer products, healthcare, software and I.T. industries. Paul is registered with FINRA as a Series 79 Investment Banking Representative.
Education: B.S. Miami University
Mariya Pylypiv, PHD, Associate
Mariya Pylypiv, associate, has over 10 years of experience in financial industry research, investments and strategy development planning. Before joining Sikich, Mariya oversaw operations and trading for a quantitative hedge fund (AUM $350 million peak assets) and was responsible for the development of new equity strategies. Mariya is also an author and a co-founder of a health care at-home delivery company and serves as its Chief Financial Officer. The company is in the process of being publicly listed. Mariya is registered with FINRA as a Series 79 Investment Banking Representative.
Education: Ph.D., Behavioral Finance/Development Economics, Purdue University,
M.A. and B.A., Accounting, Vasyl Stefanyk Precarpathian National University,
M.A. and B.A., International Economics, Ternopil National Economic University
Nate Kibby, Analyst
Nate Kibby, analyst, has more than four years of experience in finance-related industries. Nate plays an active role in financial modeling and analysis, business development, industry research, and the preparation of marketing materials, including pitch books, memorandums, and other presentations. Nate is responsible for profiling companies and assists in the identification of buyers and acquisition targets for corporate and private equity clients. Nate is registered with FINRA as a Series 79 Investment Banking Representative.
Education: B.B.A. University of Iowa